Archford Capital Strategies’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Archford Capital Strategies’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-25	Closed	-$1K	–	767
2018 Q1	$1K	Buy	+25	New	+$2.28K	﹤0.01%	642
2017 Q2	–	Sell	-25	Closed	-$1K	–	708
2017 Q1	$1K	Buy	+25	New	+$1.23K	﹤0.01%	699

Archford Capital Strategies's BIVV Position: Q2 2018 in Review

Archford Capital Strategies sold out of Bioverativ Inc. Common Stock (BIVV) in Q2 2018, closing a stake of 25 shares — an estimated $1K sold.

Archford Capital Strategies first reported a position in BIVV in Q1 2017 and held it in 2 quarters. The position peaked at $1K in Q1 2018. 0 funds tracked by Wall St. Rank hold BIVV as of Q2 2018.

Archford Capital Strategies reported no remaining Bioverativ Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
Archford Capital Strategies sold 25 Bioverativ Inc. Common Stock shares in Q2 2018, an estimated $1K.
Archford Capital Strategies first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 2 quarters.
Archford Capital Strategies's Bioverativ Inc. Common Stock position peaked at $1K in Q1 2018.
0 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q2 2018.

Based on Archford Capital Strategies's 13F filing for Q2 2018, filed 14 Aug 2018.